When we think about managing our health, diet and exercise are usually at the forefront of the conversation. However, one critical aspect often overlooked is the importance of glucose levels and how they fluctuate throughout the day.

Continuous glucose monitoring (CGM) technologies have transformed diabetes management by providing real-time, accurate glucose readings. These systems make it easier for individuals to track how their diet and lifestyle affect their glucose levels,

Senseonics Holdings, Inc. (NYSE American: SENS) ("Senseonics" or the "Company"), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes,

There are problems within the health system that mean full patient access to training on how to use the insulin pumps will likely take years, experts say.

To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that happens, newly-funded health technologies won’t get to those most in need.